Dennis Kogan

Mendaera is building a new category of handheld robotics - designed to be deployed universally in healthcare. With our handheld robotic system, Focalist™, we aim to simplify and enhance ultrasound-guided needle procedures, a foundational procedure that underpins most patient journeys. At Mendaera, we believe these critical procedures deserve breakthrough innovation—so healthcare providers can do more, with greater confidence, for the patients who count on them. See Mendaera.com for Indications for Use.

ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI.   Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.

At Caresyntax, we are dedicated to making surgery safer and smarter. Our mission is to converge AI-powered software, devices, and clinical services to help our customers improve surgical outcomes. Our platform, an enterprise-grade surgical intelligence system, is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. It can ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics to capture a complete picture of the surgical pathway. The platform generates insights across the entire continuum of care—before the procedure with surgical workflow optimization, during surgery with real-time clinically relevant support tools, and post procedure with clinical safety modules. The platform also produces data analytics and insights for medical device companies, insurers, and other ecosystem players to innovate and drive the future of healthcare delivery. Headquartered in the US in San Francisco and internationally in Berlin, Caresyntax software is used in over 4,200 ORs globally and aids surgical teams in over 3 million procedures annually. To learn more about how we’re transforming surgical care, visit us at www.caresyntax.com.

Stratum is re-architecting the financing and management of real estate, energy and mining infrastructure assets using frontier technologies. Digitizing these assets facilitates deeper liquidity and ability to use them as collateral. Stratum’s AI native integrations allow for real-time transparency of these institutional assets - something unavailable in traditional private markets.

Mendaera is building a new category of handheld robotics - designed to be deployed universally in healthcare. With our handheld robotic system, Focalist™, we aim to simplify and enhance ultrasound-guided needle procedures, a foundational procedure that underpins most patient journeys. At Mendaera, we believe these critical procedures deserve breakthrough innovation—so healthcare providers can do more, with greater confidence, for the patients who count on them. See Mendaera.com for Indications for Use.

ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI.   Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.

Storyline Capital builds and acquires real-world businesses, using AI and systems thinking to transform how traditional industries operate and grow.